Importance of worldwide research of the patients with dermatomyositis/ polymyositis
Keywords:
Worldwide research, Dermatomyositis, PolymyositisReferences
Sasaki H, Kohsaka H. Current diagnosis and treatment of polymyositis and dermatomyositis. Vol. 28, Modern Rheumatology. Taylor and Francis Ltd; 2018. p. 913–21.
DeWane ME, Waldman R, Lu J. Dermatomyositis: Clinical features and pathogenesis. J Am Acad Dermatol. 2020;82:267–81.
Bernal-MacÃas S, Fernández-Ãvila DG, Rincón-Riaño DN, Gutiérrez JM, Rosselli D. Prevalence of inflammatory myopathies in Colombia: Demographic analysis from the National Health Registry 2012–2018. Revista Colombiana de Reumatologia. 2021;
Inés L, Casas P, Johanna A, Tolosa A, Lilian E, Rodriguez Gutiérrez A, et al. MarÃa Andrea Godoy Casadiego Viceministro de Protección Social.
Santos VA, Aragón CC, Posso-Osorio I, Obando MA, Barrera T, Zamorano L, et al. Epidemiological characterization of patients with inflammatory myopathy in a fourth level hospital in Cali, Colombia. Revista Colombiana de Reumatologia. 2021;28(2):83–8.
Obando-Valencia CR, Merchán-Galvis ÃM. Polimiositis: evolución de 4 años y agudización en 2019, caso masculino en Popayán, Cauca. Revista Médicas UIS. 2022;35(1).
Liao J, Peng X, Liu J, Xie X, Wang J. The efficacy and safety of tacrolimus in patients with dermatomyositis/ polymyositis: A meta-analysis and systematic review. Eur J Intern Med. 2023 Jan; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0953620523000249